Carina Lagerqvist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carina Lagerqvist has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anneli Ivarsson
Department of Epidemiology and Global Health Umeå University Umeå Sweden
1 shared publication Erik Jidell
Department of Transfusion Medicine Umeå University Hospital Umeå Sweden
1 shared publicationHans Stenlund
Department of Public Health and Clinical Medicine Epidemiology and Public Health Sciences Umeå University Umeå Sweden
1 shared publicationIngrid Dahlbom
Department of Women's and Children's Health Sweden
1 shared publicationOlle Hernell
Department of Clinical Sciences Pediatrics Sweden
1 shared publicationPer Juto
Department of Clinical Microbiology Virology Sweden
1 shared publication
Latest Publications
- 1 October 2008
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 47 (4) , 428-435
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
Objectives: The aim was to investigate age‐dependent serum levels and occurrence of elevated celiac disease (CD)–related antibodies in young children, to define the optimal serological procedure when selecting for small intestinal biopsy.Patients and Methods: Included were 428 children with biopsy verified CD (median age 16 months; range 7.5 months–14 years) and 216 controls (median age 2.7 years; range 8.5 months–14.6 years). Immunoglobulin (Ig) A antibodies against gliadin (AGA‐IgA), tissue transglutaminase (tTG‐IgA), and endomysium (EMA‐IgA) were analysed.Results: Increased serum AGA‐IgA levels were found in 411 of 428 CD cases, tTG‐IgA in 385 of 428, and EMA‐IgA in 383 of 428. In the control group, 11 of 216 had increased levels of AGA‐IgA, 5 of 216 of tTG‐IgA, and 8 of 216 of EMA‐IgA. In CD children younger than 18 months, elevated AGA‐IgA occurred in 97% and elevated tTG‐IgA and EMA‐IgA were found in 83% of the cases. Conversely, in CD children older than 18 months, elevated AGA‐IgA occurred in 94%, and elevated tTG‐IgA and EMA‐IgA were found in 99% of the cases.Conclusions: In children older than 18 months, both tTG‐IgA and EMA‐IgA are sufficiently accurate to be used as a single antibody marker, whereas a large proportion of younger children with CD lack these antibodies. Therefore, when selecting children for small intestinal biopsy, the detection of a combination of AGA‐IgA and tTG‐IgA is optimal for identifying untreated CD in children younger than 18 months.
- 1 October 2008
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 47 (4) , 428-435
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
Objectives: The aim was to investigate age‐dependent serum levels and occurrence of elevated celiac disease (CD)–related antibodies in young children, to define the optimal serological procedure when selecting for small intestinal biopsy.Patients and Methods: Included were 428 children with biopsy verified CD (median age 16 months; range 7.5 months–14 years) and 216 controls (median age 2.7 years; range 8.5 months–14.6 years). Immunoglobulin (Ig) A antibodies against gliadin (AGA‐IgA), tissue transglutaminase (tTG‐IgA), and endomysium (EMA‐IgA) were analysed.Results: Increased serum AGA‐IgA levels were found in 411 of 428 CD cases, tTG‐IgA in 385 of 428, and EMA‐IgA in 383 of 428. In the control group, 11 of 216 had increased levels of AGA‐IgA, 5 of 216 of tTG‐IgA, and 8 of 216 of EMA‐IgA. In CD children younger than 18 months, elevated AGA‐IgA occurred in 97% and elevated tTG‐IgA and EMA‐IgA were found in 83% of the cases. Conversely, in CD children older than 18 months, elevated AGA‐IgA occurred in 94%, and elevated tTG‐IgA and EMA‐IgA were found in 99% of the cases.Conclusions: In children older than 18 months, both tTG‐IgA and EMA‐IgA are sufficiently accurate to be used as a single antibody marker, whereas a large proportion of younger children with CD lack these antibodies. Therefore, when selecting children for small intestinal biopsy, the detection of a combination of AGA‐IgA and tTG‐IgA is optimal for identifying untreated CD in children younger than 18 months.